Tapewire

Nasdaq · USD

GANX

Gain Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6943
SEC CIK
0001819411
Parsed reports
80

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 15, 2026 Filed Jul 17, 2026 12:33 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001104659-26-084439 · tm2620629-6_4seq1.xml · derivative · entry 1

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-07-15

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 12:32 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001104659-26-084438 · tm2620629-5_4seq1.xml · derivative · entry 1

Nicaise Claude · CIK 0001644162 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-07-15

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 12:32 UTC
Islam KhalidDirector
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001104659-26-084437 · tm2620629-4_4seq1.xml · derivative · entry 1

Islam Khalid · CIK 0001701858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-07-15

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 12:31 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001104659-26-084435 · tm2620629-3_4seq1.xml · derivative · entry 1

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-07-15

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 12:31 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001104659-26-084434 · tm2620629-2_4seq1.xml · derivative · entry 1

Riley Jeffrey Scott · CIK 0001487645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-07-15

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 12:30 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001104659-26-084433 · tm2620629-1_4seq1.xml · derivative · entry 1

HASLER HANS PETER · CIK 0001226286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-07-15

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:01 UTC
Mack GeneDirector · CEO, President
GrantEmployee Stock Option (right to buy) · Derivative 200,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001104659-26-035403 · tm269848-2_4seq1.xml · derivative · entry 1

Mack Gene · CIK 0001737979 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares underlying the option shall vest as to 25% on March 24, 2027, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
March 24, 2026 Filed Mar 27, 2026 00:00 UTC GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001104659-26-035400 · tm269848-1_4seq1.xml · derivative · entry 1

Fuggetta Gianluca · CIK 0001958188 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares underlying the option shall vest 25% on March 24, 2027, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
June 24, 2025 Filed Jun 25, 2025 21:30 UTC
Islam KhalidDirector
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001641172-25-016541 · ownership.xml · derivative · entry 1

Islam Khalid · CIK 0001701858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2025 Filed Jun 25, 2025 21:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001641172-25-016535 · ownership.xml · derivative · entry 1

Nicaise Claude · CIK 0001644162 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2025 Filed Jun 25, 2025 21:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001641172-25-016540 · ownership.xml · derivative · entry 1

Riley Jeffrey Scott · CIK 0001487645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2025 Filed Jun 25, 2025 21:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001641172-25-016537 · ownership.xml · derivative · entry 1

RICHMAN ERIC I · CIK 0001313876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2025 Filed Jun 25, 2025 21:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001641172-25-016539 · ownership.xml · derivative · entry 1

HASLER HANS PETER · CIK 0001226286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2025 Filed Jun 25, 2025 21:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001641172-25-016536 · ownership.xml · derivative · entry 1

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2025 Filed Jun 25, 2025 21:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001641172-25-016538 · ownership.xml · derivative · entry 1

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
March 20, 2025 Filed Mar 22, 2025 00:00 UTC GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.29 $0.00
Disclosure

SEC source: 0001493152-25-011179 · ownership.xml · derivative · entry 1

Fuggetta Gianluca · CIK 0001958188 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-03-20

F1 · derivative.exercise_date: The shares underlying the option shall vest 25% on March 20, 2026, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
March 20, 2025 Filed Mar 22, 2025 00:00 UTC
Mack GeneDirector · CEO, President
GrantEmployee Stock Option (right to buy) · Derivative 200,000 $0.00 Strike: $2.29 $0.00
Disclosure

SEC source: 0001493152-25-011175 · ownership.xml · derivative · entry 1

Mack Gene · CIK 0001737979 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2035-03-20

F1 · derivative.exercise_date: The shares underlying the option shall vest as to 25% on March 20, 2026, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 02:00 UTC
Mack GeneDirector · CEO, President
GrantStock Option (right to buy) · Derivative 271,325 $0.00 Strike: $2.44 $0.00
Disclosure

SEC source: 0001493152-25-001281 · ownership.xml · derivative · entry 1

Mack Gene · CIK 0001737979 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,325

Underlying: Common Stock · 271,325 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The shares underlying the option shall vest as to 25% on January 6, 2026 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
August 09, 2024 Filed Aug 12, 2024 21:23 UTC
Mack GeneCFO and Interim CEO
PurchaseCommon Stock 14,400 $1.01 $14,544.00
Disclosure

SEC source: 0001493152-24-031378 · ownership.xml · nonDerivative · entry 1

Mack Gene · CIK 0001737979 · CFO and Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,400

F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.98 to $1.07 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Read SEC document
August 09, 2024 Filed Aug 12, 2024 21:23 UTC
Islam KhalidDirector · Executive Chairman
PurchaseCommon Stock 50,000 $1.00 $49,940.00
Disclosure

SEC source: 0001493152-24-031377 · ownership.xml · nonDerivative · entry 2

Islam Khalid · CIK 0001701858 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F2 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.9814 to $1.00 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Read SEC document
July 01, 2024 Filed Jul 1, 2024 21:00 UTC PurchaseCommon Stock 12,000 $1.21 $14,520.00
Disclosure

SEC source: 0001493152-24-025831 · ownership.xml · nonDerivative · entry 2

RICHMAN ERIC I · CIK 0001313876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,629

Read SEC document
July 01, 2024 Filed Jul 1, 2024 21:00 UTC PurchaseCommon Stock 5,000 $1.23 $6,150.00
Disclosure

SEC source: 0001493152-24-025831 · ownership.xml · nonDerivative · entry 1

RICHMAN ERIC I · CIK 0001313876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,629

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC
Islam KhalidDirector
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001493152-24-025342 · ownership.xml · derivative · entry 1

Islam Khalid · CIK 0001701858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001493152-24-025338 · ownership.xml · derivative · entry 1

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001493152-24-025341 · ownership.xml · derivative · entry 1

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001493152-24-025339 · ownership.xml · derivative · entry 1

HASLER HANS PETER · CIK 0001226286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001493152-24-025336 · ownership.xml · derivative · entry 1

Nicaise Claude · CIK 0001644162 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001493152-24-025335 · ownership.xml · derivative · entry 1

RICHMAN ERIC I · CIK 0001313876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001493152-24-025337 · ownership.xml · derivative · entry 1

Riley Jeffrey Scott · CIK 0001487645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date.

Read SEC document
April 08, 2024 Filed Apr 8, 2024 23:44 UTC
Mack GeneChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 200,000 $0.00 Strike: $3.56 $0.00
Disclosure

SEC source: 0001493152-24-013983 · ownership.xml · derivative · entry 1

Mack Gene · CIK 0001737979 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-04-08

F1 · derivative.exercise_date: The shares underlying the option shall vest 25% on April 8, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 20:01 UTC PurchaseCommon Stock 30,000 $3.86 $115,770.00
Disclosure

SEC source: 0001493152-24-012340 · ownership.xml · nonDerivative · entry 1

Riley Jeffrey Scott · CIK 0001487645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7098 to $3.924, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 01:00 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 637 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-011836 · ownership.xml · derivative · entry 7

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,376

Underlying: Common Stock · 192 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F3 · derivative.expiration_date: The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 01:00 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 825 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-011836 · ownership.xml · derivative · entry 6

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,250

Underlying: Common Stock · 249 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F4 · derivative.expiration_date: The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 01:00 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 18,750 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-011836 · ownership.xml · derivative · entry 5

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,250

Underlying: Common Stock · 18,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F3 · derivative.expiration_date: The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 01:00 UTC
Alder MatthiasDirector · Chief Executive Officer
Tax withholdingCommon Stock 6,085 $4.06 $24,705.10
Disclosure

SEC source: 0001493152-24-011836 · ownership.xml · nonDerivative · entry 4

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,140

F2 · acquired: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 01:00 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionCommon Stock 637 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-011836 · ownership.xml · nonDerivative · entry 3

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 01:00 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionCommon Stock 825 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-011836 · ownership.xml · nonDerivative · entry 2

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,588

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 01:00 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionCommon Stock 18,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-011836 · ownership.xml · nonDerivative · entry 1

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
March 21, 2024 Filed Mar 26, 2024 01:30 UTC
Alder MatthiasDirector · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 370,000 $0.00 Strike: $4.37 $0.00
Disclosure

SEC source: 0001493152-24-011215 · ownership.xml · derivative · entry 1

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 370,000

Underlying: Common Stock · 370,000 shares

Expires 2034-03-21

F1 · derivative.exercise_date: The shares underlying the option shall vest 25% on March 21, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
March 21, 2024 Filed Mar 26, 2024 01:30 UTC GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.37 $0.00
Disclosure

SEC source: 0001493152-24-011216 · ownership.xml · derivative · entry 1

Fuggetta Gianluca · CIK 0001958188 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-03-21

F1 · derivative.exercise_date: The shares underlying the option shall vest 25% on March 21, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
December 21, 2023 Filed Dec 22, 2023 21:17 UTC
Alder MatthiasDirector · Chief Executive Officer
SaleCommon Stock 206 $2.46 $506.76
Disclosure

SEC source: 0001209191-23-059558 · doc4.xml · nonDerivative · entry 2

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,286

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4602 to $2.485 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 20, 2023 Filed Dec 22, 2023 21:17 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 637 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-059558 · doc4.xml · derivative · entry 3

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,013

Underlying: Common Stock · 637 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The RSUs vested 25% on September 20, 2023 and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F3 · derivative.expiration_date: The RSUs vested 25% on September 20, 2023 and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
December 20, 2023 Filed Dec 22, 2023 21:17 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionCommon Stock 637 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-059558 · doc4.xml · nonDerivative · entry 1

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
December 07, 2023 Filed Dec 14, 2023 21:01 UTC
Alder MatthiasDirector · Chief Executive Officer
SaleCommon Stock 1,820 $2.50 $4,550.00
Disclosure

SEC source: 0001104659-23-126020 · tm2332941-1_4seq1.xml · nonDerivative · entry 1

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,855

F1 · shares: Reflects shares sold to cover withholding taxes incurred upon the vesting and settlement of restricted stock units in a trade that was initiated by the Issuer on the Reporting Person's behalf.

F2 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.48 to $2.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote.

Read SEC document
October 01, 2023 Filed Oct 3, 2023 20:36 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 825 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-051502 · doc4.xml · derivative · entry 2

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,075

Underlying: Common Stock · 825 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F2 · derivative.expiration_date: The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
October 01, 2023 Filed Oct 3, 2023 20:36 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionCommon Stock 825 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-051502 · doc4.xml · nonDerivative · entry 1

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,675

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
September 20, 2023 Filed Sep 22, 2023 20:34 UTC Exercise / conversionRestricted Stock Units · Derivative 54,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-050380 · doc4.xml · derivative · entry 3

RICHMAN ERIC I · CIK 0001313876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 54,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The RSUs vested fully on September 20, 2023.

F3 · derivative.expiration_date: The RSUs vested fully on September 20, 2023.

Read SEC document
September 20, 2023 Filed Sep 22, 2023 20:34 UTC Exercise / conversionCommon Stock 54,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-050380 · doc4.xml · nonDerivative · entry 1

RICHMAN ERIC I · CIK 0001313876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
September 20, 2023 Filed Sep 22, 2023 20:34 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 2,550 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-050379 · doc4.xml · derivative · entry 2

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,650

Underlying: Common Stock · 2,550 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The RSUs vested 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F2 · derivative.expiration_date: The RSUs vested 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

Read SEC document
September 20, 2023 Filed Sep 22, 2023 20:34 UTC
Alder MatthiasDirector · Chief Executive Officer
Exercise / conversionCommon Stock 2,550 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-050379 · doc4.xml · nonDerivative · entry 1

Alder Matthias · CIK 0001370820 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.